Chemically modified small molecules
View Patent ↗The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer obtained from a monodisperse or bimodal water-soluble oligomer composition. A conjugate of the invention, when administered by any of a number of administration routes, exhibits a reduced biological membrane crossing rate as compared to the biological membrane crossing rate of the small molecule drug not attached to the water-soluble oligomer.
1. 6-CH 3 —(OCH 2 CH 2 ) 7 —O-Naloxol or a pharmaceutically acceptable salt thereof.
2. α-6-CH 3 —(OCH 2 CH 2 ) 7 —O-Naloxol or a pharmaceutically acceptable salt thereof.
3. β-6-CH 3 —(OCH 2 CH 2 ) 7 —O-Naloxol or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising the compound of any one of claims 1 - 3 , or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.